CHLOE MURRAY: Open Payments
NPI 1871159376 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 13 companies in 2025. Trend: 2023 $73 · 2024 $730 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Exact Sciences Corporation | 1 | $29 |
| ABBVIE INC. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Noven Therapeutics, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: INGREZZA, Cologuard Collection Kit, REXULTI, Xelstrym, Jornay PM, XIFAXAN, Auvelity, FANAPT.
Industry payments across FL — which companies pay providers there.
